Key Insights

Highlights

Treatment Research

4 treatments under study, led by Microscope Integrated Optical Coherence Tomography

Research Leaders

6 sponsors active, led by Intalight, Inc

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Unknown1
Active Not Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT03713268Recruiting

Intraoperative OCT Guidance of Intraocular Surgery II

NCT07449195Not ApplicableRecruitingPrimary

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

NCT05051384Not ApplicableActive Not RecruitingPrimary

Superb Microvascular Intraocular Tumor Imaging Study (SMITIS)

NCT04695015Unknown

Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

Showing all 4 trials

Research Network

Common Treatments

  • Microscope Integrated Optical Coherence Tomography1
  • Doppler Technology1
  • Heidelberg Spectralis Oct1
  • Intalight Dream Oct1

Active Sponsors

  • Intalight, Inc1
  • Centre Hospitalier Universitaire de Nice1
  • Duke University1
  • National Eye Institute (NEI)1
  • Peking University1

Top Investigators

Related Conditions

  • Basal Cell Carcinoma1
  • Diabetic Retinopathy1
  • Healthy1
  • Preretinal Fibrosis1
  • Sebaceous Gland Carcinoma Of The Eyelid1

Activity Timeline